We want to revolutionize health and quality of life for patients with challenges

Jeppe Krog Rasmussen, Founder and CEO at DanCann Pharma since its formation in 2018. Jeppe has been a part of the whole DanCann Pharma journey since its beginning back in March 2018, where he founded the Company. Jeppe is responsible for the strategic direction and operational execution of all processes relevant to DanCann Pharma. In addition to DanCann Pharma Jeppe runs his investment company, JKR Investment Group ApS, where he manages his investment portfolio.

Carsten Trads holds a B.Sc. from Copenhagen Business School, complemented by management training from INSEAD and Harvard Business School.Carsten has more than 30 years international experience within sales, marketing, operations, strategic planning and general management. Executive positions in companies such as Bang & Olufsen A/S, GN ReSound A/S and Plantronics Inc. From 2015 he has been the CEO and owner of C-Plus Consult, assisting small business startups.

Alexander Schoeneck is the chairman of the board in JEQ Capital, a fund with focus on small companies in an early stage. Board member in Corpura Fondkommission, EllWee AB (listed on Nasdaq First North), JEQ Capital Holding, Corpura Holding, Campingstugan Invest, Black Lion Media Group AB, Glassaparken AB and JJV Invest AB. Alexander has great experience when it comes to the financial markets, corporate finance, and investor relations.

Tue is an experienced investment profile, who is CEO of the fast-growing HC Andersen Capital. He has engaged himself as an investor, founder, advisor, mentor and board member in a number of companies.With his many years of experience in executive leadership and board membership roles in companies such as HC Andersen Capital, Green Mobility A/S, ABG Sundal Collier and Nordea, Tue has the expertise needed to contribute to the further development of DanCann Pharma’s business.

Christian Carlsen holds an executive MBA from Henley Business School complemented by management training from INSEAD and Harvard Business School.Christian Carlsen has previously worked for companies such as Bavarian Nordic A/S, Labflex A/S and Novo Nordisk Engineering A/S (NNE). At NNE Christian Carlsen led several strategic projects and activities, including leading an initiative to establish a corporate venture business and establishing a unit with a focus on business model innovation, venture incubation and partnerships.Christian has a long track record of starting, developing and transforming life science and tech companies both in a startup and corporate environment.